- Published on
Ophthalmology – Epiretinal Membranes (ERM)
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
Epiretinal membranes (ERM), also known as macular pucker, cellophane maculopathy, or surface wrinkling retinopathy, are thin fibrocellular layers that form on the inner surface of the retina, particularly over the macula. While many cases are mild and asymptomatic, ERMs can distort the retinal architecture, leading to blurred vision and metamorphopsia (distorted vision). They are commonly associated with posterior vitreous detachment (PVD) and may coexist with vitreomacular traction.
ERM is primarily a disease of the elderly population, with prevalence increasing significantly with age. It is found in about 2% of individuals at age 50, rising to 20% by age 75. Although bilateral in 20–30% of cases, it is often asymmetric. Risk factors include female gender, aging, prior ocular surgery or trauma, diabetes, retinal vascular disease, intraocular inflammation, and vitreous hemorrhage. Pediatric cases are rare and usually secondary to other ocular abnormalities.
The pathophysiology involves abnormal proliferation of glial cells (including Müller cells, astrocytes, fibrocytes, and myofibroblasts) on the retinal surface. These cells often migrate after a posterior vitreous detachment, although they may appear earlier. Over time, these cells can acquire contractile properties, exerting traction on the retina and leading to wrinkling, distortion, and reduced visual acuity.
ERM can be classified as idiopathic (primary) or secondary. Idiopathic ERMs occur without an identifiable cause, while secondary ERMs develop in association with retinal vascular diseases, inflammation, trauma, or prior surgery.
Clinically, many patients are asymptomatic, especially in early stages. Symptomatic patients may report gradual vision loss, distortion of straight lines (metamorphopsia), difficulty reading, or central blurring. Occasionally, patients may experience diplopia or photopsias.
On examination, subtle ERMs may appear as a shiny, glistening reflex on the macula, while more advanced cases show retinal folds (striae), vessel tortuosity, and macular thickening. In some cases, cystoid macular edema (CME) or small hemorrhages may be present due to traction.
Diagnosis is primarily clinical but is best confirmed with imaging. Optical coherence tomography (OCT) is the gold standard and demonstrates retinal surface wrinkling, thickening, and possible cystoid changes. OCT also helps assess prognosis, as disruption of photoreceptor layers or significant edema correlates with poorer outcomes. Fluorescein angiography (FA) may be used to evaluate for underlying vascular disease or macular leakage. Amsler grid testing is useful for monitoring visual distortion.
The differential diagnosis includes proliferative diabetic retinopathy, retinal vein occlusion-related fibrosis, and incomplete posterior vitreous detachment with adherent posterior hyaloid.
Management depends on symptom severity. Asymptomatic patients require no treatment and can be observed with periodic follow-up. For patients with mild edema, topical NSAIDs or steroids may be used. However, medical therapy is generally limited in effectiveness for ERM itself.
Definitive treatment is surgical, indicated in patients with significant visual symptoms or visual acuity worse than ~20/40. The procedure involves pars plana vitrectomy with membrane peeling, often including removal of the internal limiting membrane (ILM) to reduce recurrence risk. Advances in minimally invasive vitrectomy have improved recovery times and outcomes.
Follow-up includes routine monitoring and Amsler grid use, with prompt reassessment if symptoms worsen. Many ERMs remain stable for years, but progression can occur, especially after acute PVD or ocular surgery.
The prognosis is generally favorable. Asymptomatic patients maintain good vision, while 80–90% of surgical patients experience improvement of at least two Snellen lines. However, complete restoration to normal vision (20/20) is uncommon, and outcomes depend largely on preoperative visual acuity and retinal integrity.
Complications include cataract formation (most common), retinal tears or detachment, recurrent ERM, retinal phototoxicity, and rarely endophthalmitis.
- Published on
Ophthalmology – Epiphora
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
Epiphora, commonly referred to as excessive tearing, results from an imbalance between tear production and tear drainage. Tears are produced by the lacrimal glands and normally drain through the nasolacrimal system into the nose. Any disruption in this balance—either overproduction due to irritation or impaired drainage due to obstruction—can lead to tearing.
Epidemiologically, epiphora shows a bimodal distribution, occurring most often in infants and older adults. In infants, the most common cause is congenital nasolacrimal duct obstruction, affecting about 5% of newborns, with 90% resolving spontaneously by age 1. In adults, tearing is frequently due to dry eye syndrome, particularly in postmenopausal women, where ocular surface irritation leads to reflex tearing.
The pathophysiology involves disruption of the normal tear film dynamics. Tears consist of aqueous, lipid, and mucin layers that maintain ocular surface health. Blinking helps pump tears into the drainage system. In infants, incomplete canalization of the nasolacrimal duct leads to obstruction. In adults, dry eye or tear film instability causes irritation and reflex tearing. Other contributors include blepharitis (affecting lipid layer), decreased tear production, eyelid malposition (e.g., ectropion), or obstruction from inflammation, trauma, or infection.
Etiologically, epiphora can be broadly divided into overproduction and outflow obstruction. Overproduction is usually secondary to ocular surface irritation, such as from trichiasis, entropion, keratitis, uveitis, conjunctivitis, or foreign bodies. Outflow obstruction may occur anywhere along the lacrimal drainage pathway due to infection (dacryocystitis), inflammation, trauma, or medication-induced stenosis. Poor tear pump function from eyelid laxity or facial nerve palsy may also contribute.
Clinically, infants present with constant tearing shortly after birth, often accompanied by crusting of eyelashes, especially after sleep, and symptoms may worsen with nasal congestion. Adults with dry eye typically report intermittent tearing, worsened by activities that reduce blinking (e.g., reading, screen use, driving) or environmental factors like wind and cold air. In contrast, patients with obstruction often have constant tearing and may have a history of infection or trauma.
Physical examination includes assessment of the tear film quality and quantity, eyelid position (looking for entropion, ectropion, or misdirected lashes), and ocular surface for signs of dry eye or inflammation. Evaluation of the lacrimal drainage system includes inspection of the puncta, canaliculi, and lacrimal sac, with palpation to check for reflux of discharge suggestive of obstruction or infection.
Diagnostic testing may include the fluorescein dye disappearance test, where persistence of dye suggests impaired drainage. Schirmer testing evaluates tear production, with less than 5 mm of wetting in 5 minutes indicating dry eye. Additional studies such as dacryocystography or lacrimal scintigraphy can help differentiate obstruction from pump failure. Imaging (CT scan) may be used if structural abnormalities, cysts, or tumors are suspected. Lacrimal irrigation in-office is a useful diagnostic tool in older children and adults.
The differential diagnosis varies by age. In children, causes include congenital nasolacrimal duct obstruction, congenital glaucoma, and epiblepharon. In adults, common causes include dry eye, nasolacrimal duct obstruction, eyelid malposition, trichiasis, and facial nerve palsy, while acute causes include conjunctivitis, keratitis, uveitis, or foreign body.
Management depends on the underlying cause. In infants, conservative treatment includes topical antibiotic ointment for discharge and lacrimal sac massage, which can help open the duct. Most cases resolve spontaneously. In adults with dry eye, artificial tears are first-line, with second-line options including topical cyclosporine or short-term steroids for inflammation. Acute causes require treatment of the underlying condition, such as antibiotics for infection or removal of a foreign body.
Procedural interventions include punctal occlusion for dry eye, punctoplasty for stenosis, and probing and irrigation for congenital obstruction. Surgical options such as dacryocystorhinostomy (DCR) are used for persistent nasolacrimal duct obstruction. Eyelid malpositions may require entropion or ectropion repair.
Follow-up varies by age and severity. Infants are typically observed during the first year, with surgery considered if symptoms persist beyond age 1. Adults are managed based on cause, with surgical follow-up as needed. Prognosis is excellent in pediatric cases, while in adults it depends on the underlying etiology—patients with obstruction often do well after surgery, whereas those with chronic dry eye may have ongoing intermittent symptoms.
- Published on
Ophthalmology – Enophthalmos
Enophthalmos refers to the posterior displacement of a normal-sized globe within the orbit, giving the appearance of a “sunken eye.” It can be congenital or acquired, with acquired causes being more common in clinical practice. The condition may develop gradually or suddenly, depending on the underlying etiology, and can be unilateral or bilateral.
The underlying pathophysiology depends on the cause. Congenital enophthalmos results from abnormal orbital development during fetal life. Acquired forms arise from mechanisms such as loss of orbital volume (fat atrophy), structural changes in the orbit (e.g., fractures or sinus disease), or fibrotic traction pulling the globe backward. Enlargement of the orbital cavity or loss of support from the orbital floor may also lead to associated hypoglobus (downward displacement of the globe).
Etiologically, enophthalmos can be grouped into three major categories: structural abnormalities, fat atrophy, and tractional causes. Common causes include orbital floor fractures, especially following trauma, postsurgical changes (such as orbital decompression or tumor removal), and silent sinus syndrome, where chronic maxillary sinus collapse leads to orbital floor descent. Other causes include orbital fat atrophy (e.g., due to radiation or systemic wasting), metastatic scirrhous carcinoma (notably breast cancer) causing fibrotic contraction, and orbital venous malformations. Neurologic and congenital conditions such as Duane retraction syndrome may also be associated.
Patients often report a gradual sinking of the eye or asymmetry in appearance. Some may notice a droopy eyelid or deepened upper eyelid sulcus, and historical photographs can be useful for comparison. On examination, key findings include deepened superior sulcus, narrowed palpebral fissure, and posterior displacement of the globe. Measurement with Hertel exophthalmometry can help quantify asymmetry, although it may be less useful in bilateral cases. Additional findings such as skin thinning (in atrophy) or thickening (in malignancy), as well as ocular motility or sensory deficits, may provide clues to the underlying cause. A full ocular exam is essential to assess visual acuity and optic nerve function, including evaluation for an afferent pupillary defect.
Imaging plays a crucial role in diagnosis. A CT scan of the orbits (axial and coronal views) is the primary modality to evaluate bony structures and orbital volume changes. If inflammatory or neoplastic causes are suspected, an MRI with contrast and fat suppression is indicated. In uncertain cases, orbital biopsy (orbitotomy) may be required for definitive diagnosis.
The differential diagnosis includes pseudo-enophthalmos, where the globe appears sunken but is actually normal in position. Causes include contralateral proptosis, Horner syndrome, phthisis bulbi, and microphthalmos.
Management depends on the underlying etiology. Orbital fractures may require surgical repair to restore orbital volume. Silent sinus syndrome is treated with functional endoscopic sinus surgery to re-aerate the sinus. In cases of volume loss, orbital augmentation with implants or fillers (e.g., hyaluronic acid) may be used. Oncologic causes require appropriate systemic evaluation and treatment.
Follow-up involves monitoring by an ophthalmologist, and in cases involving sinus disease, collaboration with an otolaryngologist is important. Patients should be advised to avoid nose blowing or forceful sneezing (with a closed mouth), particularly if an orbital fracture is suspected.
Chronic enophthalmos can be difficult to fully correct, especially if longstanding, and may lead to persistent cosmetic and functional concerns if not addressed early.
Enophthalmos refers to the posterior displacement of a normal-sized globe within the orbit, giving the appearance of a “sunken eye.” It can be congenital or acquired, with acquired causes being more common in clinical practice. The condition may develop gradually or suddenly, depending on the underlying etiology, and can be unilateral or bilateral.
The underlying pathophysiology depends on the cause. Congenital enophthalmos results from abnormal orbital development during fetal life. Acquired forms arise from mechanisms such as loss of orbital volume (fat atrophy), structural changes in the orbit (e.g., fractures or sinus disease), or fibrotic traction pulling the globe backward. Enlargement of the orbital cavity or loss of support from the orbital floor may also lead to associated hypoglobus (downward displacement of the globe).
Etiologically, enophthalmos can be grouped into three major categories: structural abnormalities, fat atrophy, and tractional causes. Common causes include orbital floor fractures, especially following trauma, postsurgical changes (such as orbital decompression or tumor removal), and silent sinus syndrome, where chronic maxillary sinus collapse leads to orbital floor descent. Other causes include orbital fat atrophy (e.g., due to radiation or systemic wasting), metastatic scirrhous carcinoma (notably breast cancer) causing fibrotic contraction, and orbital venous malformations. Neurologic and congenital conditions such as Duane retraction syndrome may also be associated.
Patients often report a gradual sinking of the eye or asymmetry in appearance. Some may notice a droopy eyelid or deepened upper eyelid sulcus, and historical photographs can be useful for comparison. On examination, key findings include deepened superior sulcus, narrowed palpebral fissure, and posterior displacement of the globe. Measurement with Hertel exophthalmometry can help quantify asymmetry, although it may be less useful in bilateral cases. Additional findings such as skin thinning (in atrophy) or thickening (in malignancy), as well as ocular motility or sensory deficits, may provide clues to the underlying cause. A full ocular exam is essential to assess visual acuity and optic nerve function, including evaluation for an afferent pupillary defect.
Imaging plays a crucial role in diagnosis. A CT scan of the orbits (axial and coronal views) is the primary modality to evaluate bony structures and orbital volume changes. If inflammatory or neoplastic causes are suspected, an MRI with contrast and fat suppression is indicated. In uncertain cases, orbital biopsy (orbitotomy) may be required for definitive diagnosis.
The differential diagnosis includes pseudo-enophthalmos, where the globe appears sunken but is actually normal in position. Causes include contralateral proptosis, Horner syndrome, phthisis bulbi, and microphthalmos.
Management depends on the underlying etiology. Orbital fractures may require surgical repair to restore orbital volume. Silent sinus syndrome is treated with functional endoscopic sinus surgery to re-aerate the sinus. In cases of volume loss, orbital augmentation with implants or fillers (e.g., hyaluronic acid) may be used. Oncologic causes require appropriate systemic evaluation and treatment.
Follow-up involves monitoring by an ophthalmologist, and in cases involving sinus disease, collaboration with an otolaryngologist is important. Patients should be advised to avoid nose blowing or forceful sneezing (with a closed mouth), particularly if an orbital fracture is suspected.
Chronic enophthalmos can be difficult to fully correct, especially if longstanding, and may lead to persistent cosmetic and functional concerns if not addressed early.
- Published on
Ophthalmology – Endophthalmitis
Endophthalmitis is a severe, vision-threatening intraocular inflammatory condition involving the vitreous and aqueous humors, most commonly due to infection. It is considered an ophthalmic emergency, as rapid progression can lead to permanent vision loss or blindness. The condition is broadly classified into infectious (postoperative, posttraumatic, or endogenous) and noninfectious (sterile) forms, the latter mimicking infection clinically.
Most cases are postoperative (approximately 75%), particularly following cataract surgery, with an incidence of about 0.05–0.16%. Posttraumatic cases account for about 20%, often associated with penetrating injuries or retained intraocular foreign bodies. Endogenous cases (around 5%) occur when infection spreads hematogenously from a distant systemic source, typically in immunocompromised individuals, intravenous drug users, or patients with indwelling catheters.
The pathophysiology involves rapid microbial proliferation within the vitreous cavity, followed by a robust inflammatory response. Within 24 hours, inflammatory cells infiltrate ocular tissues, and by 48 hours, irreversible photoreceptor damage may occur. Even after microbial control, inflammatory mediators and endotoxins may continue to damage intraocular structures.
Patients typically present with acute onset of eye pain, decreased vision, and redness, often with a history of recent surgery, trauma, or systemic infection. Examination findings may include conjunctival injection, corneal edema, hypopyon (layering of pus in the anterior chamber), anterior chamber inflammation, and dense vitreitis, often obscuring the view of the retina. Postoperative and traumatic cases are usually unilateral, while endogenous cases may be bilateral.
Diagnosis is primarily clinical but supported by investigations. A vitreous tap is performed to obtain samples for Gram stain, culture, and fungal studies. In suspected endogenous cases, blood and urine cultures may help identify the systemic source, and an echocardiogram may be required to rule out endocarditis. B-scan ultrasonography is useful when the retina cannot be visualized, helping detect vitreous inflammation or retinal detachment.
Management requires urgent intravitreal antibiotic therapy, targeting both Gram-positive and Gram-negative organisms. Common regimens include vancomycin and ceftazidime, often combined with intravitreal corticosteroids to reduce inflammation. In suspected fungal infections, intravitreal antifungal agents are used. Patients with very poor vision (light perception only) typically require pars plana vitrectomy, which removes infected vitreous material and improves drug penetration.
Close monitoring is essential, often requiring daily follow-up until stabilization. Additional treatments may include repeat intravitreal injections or delayed vitrectomy if response is inadequate. Endogenous cases require systemic evaluation and treatment of the underlying infection, often in collaboration with infectious disease specialists.
Despite advances in treatment, the prognosis remains guarded, with a significant risk of permanent vision impairment or blindness. Early diagnosis and prompt intervention greatly improve outcomes. Complications include retinal detachment and phthisis bulbi, both of which can lead to irreversible vision loss.
Endophthalmitis is a severe, vision-threatening intraocular inflammatory condition involving the vitreous and aqueous humors, most commonly due to infection. It is considered an ophthalmic emergency, as rapid progression can lead to permanent vision loss or blindness. The condition is broadly classified into infectious (postoperative, posttraumatic, or endogenous) and noninfectious (sterile) forms, the latter mimicking infection clinically.
Most cases are postoperative (approximately 75%), particularly following cataract surgery, with an incidence of about 0.05–0.16%. Posttraumatic cases account for about 20%, often associated with penetrating injuries or retained intraocular foreign bodies. Endogenous cases (around 5%) occur when infection spreads hematogenously from a distant systemic source, typically in immunocompromised individuals, intravenous drug users, or patients with indwelling catheters.
The pathophysiology involves rapid microbial proliferation within the vitreous cavity, followed by a robust inflammatory response. Within 24 hours, inflammatory cells infiltrate ocular tissues, and by 48 hours, irreversible photoreceptor damage may occur. Even after microbial control, inflammatory mediators and endotoxins may continue to damage intraocular structures.
Patients typically present with acute onset of eye pain, decreased vision, and redness, often with a history of recent surgery, trauma, or systemic infection. Examination findings may include conjunctival injection, corneal edema, hypopyon (layering of pus in the anterior chamber), anterior chamber inflammation, and dense vitreitis, often obscuring the view of the retina. Postoperative and traumatic cases are usually unilateral, while endogenous cases may be bilateral.
Diagnosis is primarily clinical but supported by investigations. A vitreous tap is performed to obtain samples for Gram stain, culture, and fungal studies. In suspected endogenous cases, blood and urine cultures may help identify the systemic source, and an echocardiogram may be required to rule out endocarditis. B-scan ultrasonography is useful when the retina cannot be visualized, helping detect vitreous inflammation or retinal detachment.
Management requires urgent intravitreal antibiotic therapy, targeting both Gram-positive and Gram-negative organisms. Common regimens include vancomycin and ceftazidime, often combined with intravitreal corticosteroids to reduce inflammation. In suspected fungal infections, intravitreal antifungal agents are used. Patients with very poor vision (light perception only) typically require pars plana vitrectomy, which removes infected vitreous material and improves drug penetration.
Close monitoring is essential, often requiring daily follow-up until stabilization. Additional treatments may include repeat intravitreal injections or delayed vitrectomy if response is inadequate. Endogenous cases require systemic evaluation and treatment of the underlying infection, often in collaboration with infectious disease specialists.
Despite advances in treatment, the prognosis remains guarded, with a significant risk of permanent vision impairment or blindness. Early diagnosis and prompt intervention greatly improve outcomes. Complications include retinal detachment and phthisis bulbi, both of which can lead to irreversible vision loss.
- Published on
Ophthalmology – Entropion
Entropion is defined as an inward rotation of the eyelid margin, causing the eyelashes and periocular skin to rub against the ocular surface. This results in chronic irritation and can lead to corneal damage if untreated. It may be classified into four types: congenital, involutional (most common), spastic, and cicatricial.
Epidemiologically, involutional entropion increases with age and is the most frequently encountered type. Spastic entropion is typically temporary, often triggered by trauma, ocular irritation, or blepharospasm. Cicatricial entropion is less common but more severe, frequently associated with ocular cicatricial pemphigoid (OCP), which tends to affect older adults (age 60–70) and occurs more often in females. OCP has a prevalence of approximately 1 in 15,000–20,000 individuals.
The pathophysiology involves multiple mechanical and structural changes. These include increased orbicularis muscle tone and override, weakening or dehiscence of the lower eyelid retractors, horizontal eyelid laxity, and atrophy of the tarsal plate. In cicatricial cases, scarring of the conjunctiva leads to inward rotation of the lid margin.
Etiologically, entropion may result from aging changes, chronic use of certain topical medications (e.g., pilocarpine, timolol, epinephrine), or systemic autoimmune conditions such as ocular cicatricial pemphigoid, a type II hypersensitivity reaction with genetic predisposition (associated with HLA-DQB1*0301). Other associated conditions include Stevens–Johnson syndrome, trachoma, trauma, and chemical burns, all of which can lead to conjunctival scarring.
Patients typically present with foreign body sensation, tearing, redness, and irritation.
On examination, the eyelid margin is visibly inverted, with eyelashes rubbing against the cornea. Findings may include conjunctival injection, superficial punctate keratopathy, corneal abrasions, and in advanced cases, corneal scarring, thinning, ulceration, or neovascularization. In cicatricial entropion, additional features such as symblepharon (adhesion between palpebral and bulbar conjunctiva) and forniceal shortening may be present.
Diagnosis is primarily clinical. Laboratory testing is generally not required unless an autoimmune etiology such as OCP is suspected. In such cases, conjunctival biopsy with immunofluorescence can confirm the diagnosis, showing antibody deposition in over 80% of cases. Ancillary markers such as ANA or inflammatory mediators may also be elevated.
The differential diagnosis includes conditions that mimic eyelash irritation, such as epiblepharon (common in children), trichiasis (misdirected lashes), and distichiasis (extra row of lashes).
Management initially focuses on protecting the ocular surface. First-line treatment includes frequent lubrication with artificial tears and ointments. Temporary measures such as taping the lower eyelid to the cheek may help reposition the lid. In cases associated with OCP, systemic immunosuppressive therapy (e.g., prednisone, methotrexate, cyclophosphamide) may be required.
Definitive treatment is surgical, and most patients will eventually require it. Procedures include horizontal eyelid tightening, retractor repair, orbicularis muscle repositioning, or marginal rotation techniques. Simple suture repairs can be performed but have a higher recurrence rate.
Close follow-up is essential, typically within one week, to monitor for corneal complications. Patients should be educated to seek urgent care if they experience increased pain, redness, tearing, or photophobia, as these may indicate corneal involvement.
The prognosis is generally good with timely surgical correction. However, cicatricial causes like OCP may follow a chronic relapsing course and can lead to progressive vision loss if not adequately managed. Serious complications include corneal ulceration, scarring, perforation, and even loss of the eye, making early recognition and treatment critical.
- Published on
Ophthalmology – Esotropia (Infantile)
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
- Published on
Ophthalmology – Conjunctival Primary Acquired Melanosis (PAM)
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
- Published on
Ophthalmology – Acute Bacterial Conjunctivitis
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
- Published on
Ophthalmology – Conjunctival Nevus
Conjunctival nevus is the most common conjunctival tumor, accounting for a large proportion of melanocytic lesions of the ocular surface. It is typically a benign proliferation of melanocytes and may be present at birth (congenital) or develop during childhood or adolescence. Most lesions become clinically noticeable in the first or second decade of life and can change in pigmentation over time, particularly during periods of hormonal change such as puberty.
Clinically, conjunctival nevi appear as well-defined, slightly elevated lesions that may be pigmented (brown) or amelanotic (nonpigmented). A key distinguishing feature is the presence of intralesional cysts, which are often visible on slit-lamp examination and help differentiate nevi from malignant lesions. These lesions are most commonly located on the bulbar conjunctiva, especially near the nasal or temporal limbus in sun-exposed areas. Importantly, they usually do not extend onto the cornea and tend to move with the conjunctiva.
Most patients are asymptomatic and simply notice a “spot on the eye.” Occasionally, mild irritation or inflammation may occur. The condition is generally sporadic and rarely associated with systemic disease, although uncommon associations with syndromes like Carney complex have been reported.
Diagnosis is primarily clinical, supported by slit-lamp examination and photographic documentation. Anterior segment OCT can help identify cystic components within the lesion. Regular follow-up with serial photography every 6–12 months is recommended to monitor for changes in size, shape, or pigmentation.
Management is usually conservative. Observation is the standard approach for typical, stable lesions. However, surgical excision may be indicated if there are suspicious features such as documented growth, absence of cysts, prominent feeder vessels, unusual location (e.g., forniceal or tarsal conjunctiva), corneal involvement, or onset later in life. Excision is performed using a “no-touch” technique with cryotherapy to margins to reduce the risk of recurrence or malignant transformation.
The prognosis is excellent in the vast majority of cases, as conjunctival nevi are benign. Malignant transformation into melanoma is rare but possible, which is why periodic monitoring is essential. Complications are uncommon but may include mild irritation or dry eye following surgical removal.
Conjunctival nevus is the most common conjunctival tumor, accounting for a large proportion of melanocytic lesions of the ocular surface. It is typically a benign proliferation of melanocytes and may be present at birth (congenital) or develop during childhood or adolescence. Most lesions become clinically noticeable in the first or second decade of life and can change in pigmentation over time, particularly during periods of hormonal change such as puberty.
Clinically, conjunctival nevi appear as well-defined, slightly elevated lesions that may be pigmented (brown) or amelanotic (nonpigmented). A key distinguishing feature is the presence of intralesional cysts, which are often visible on slit-lamp examination and help differentiate nevi from malignant lesions. These lesions are most commonly located on the bulbar conjunctiva, especially near the nasal or temporal limbus in sun-exposed areas. Importantly, they usually do not extend onto the cornea and tend to move with the conjunctiva.
Most patients are asymptomatic and simply notice a “spot on the eye.” Occasionally, mild irritation or inflammation may occur. The condition is generally sporadic and rarely associated with systemic disease, although uncommon associations with syndromes like Carney complex have been reported.
Diagnosis is primarily clinical, supported by slit-lamp examination and photographic documentation. Anterior segment OCT can help identify cystic components within the lesion. Regular follow-up with serial photography every 6–12 months is recommended to monitor for changes in size, shape, or pigmentation.
Management is usually conservative. Observation is the standard approach for typical, stable lesions. However, surgical excision may be indicated if there are suspicious features such as documented growth, absence of cysts, prominent feeder vessels, unusual location (e.g., forniceal or tarsal conjunctiva), corneal involvement, or onset later in life. Excision is performed using a “no-touch” technique with cryotherapy to margins to reduce the risk of recurrence or malignant transformation.
The prognosis is excellent in the vast majority of cases, as conjunctival nevi are benign. Malignant transformation into melanoma is rare but possible, which is why periodic monitoring is essential. Complications are uncommon but may include mild irritation or dry eye following surgical removal.
- Published on
Ophthalmology – Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE)
Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE) consists of benign melanocytic lesions of the retinal pigment epithelium (RPE). These lesions may be solitary, grouped, or multiple, and their clinical significance ranges from harmless incidental findings to markers of systemic disease.
CHRPE lesions are typically flat, well-demarcated, and darkly pigmented, appearing gray-brown to jet black. Many lesions show characteristic depigmented lacunae (pale areas) or a surrounding halo. They are most commonly located in the superotemporal fundus and usually measure about 1–2 disc diameters, though larger lesions can occur.
Three main patterns are recognized:
1. Solitary CHRPE
These are single, flat lesions with smooth or scalloped borders. They may slowly enlarge over time and can develop increasing depigmentation. They are generally benign and not associated with systemic disease.
2. Grouped CHRPE (“bear tracks”)
These consist of multiple small, round pigmented spots arranged in clusters. They are often unilateral and confined to one retinal quadrant. Despite their striking appearance, they have no systemic associations and are considered benign variants.
3. Multiple bilateral CHRPE associated with Familial adenomatous polyposis
This pattern is clinically important. Lesions are typically:
• Multiple (>4 per eye)
• Bilateral
• Oval with irregular borders
• Often show “fishtail” depigmentation at the edges
These findings may indicate an underlying mutation in the APC gene, a tumor suppressor gene responsible for familial adenomatous polyposis (FAP).
Epidemiologically, CHRPE is found in approximately 1.2% of the population, while FAP occurs in about 1 in 13,000–18,000 individuals. Notably, 70–80% of patients with FAP have CHRPE-like lesions, making this an important ocular marker.
Pathophysiologically, CHRPE arises from hypertrophy and hyperplasia of RPE cells, which contain abundant melanin. Solitary and grouped lesions are typically composed of a single layer of enlarged pigmented cells, while FAP-associated lesions may show multilayering and retinal involvement.
History is crucial, especially in patients with multiple lesions. Clinicians should ask about:
• Family history of colon cancer or polyps
• Gastrointestinal symptoms (e.g., rectal bleeding, abdominal pain)
• Associated tumors or syndromes
On examination, dilated funduscopy reveals the characteristic pigmented lesions. The presence of bilateral, multiple, widely spaced lesions should raise suspicion for FAP and prompt systemic evaluation.
Diagnostic tools include:
• Fundus photography for documentation and monitoring
• Autofluorescence imaging (lesions appear hypoautofluorescent)
• Fluorescein angiography (may show capillary changes)
• Visual field testing (for large lesions causing scotomas)
If FAP is suspected, referral for genetic testing (APC gene) and gastrointestinal evaluation is essential. Screening with colonoscopy or sigmoidoscopy typically begins in childhood (around age 10).
Management depends on the type:
• Solitary and grouped CHRPE: No treatment required; routine observation
• FAP-associated CHRPE: Requires systemic surveillance and management, including possible colectomy depending on polyp burden
Follow-up includes periodic ophthalmic examination with photographic documentation to monitor for growth or changes.
Prognosis for isolated CHRPE is excellent. Lesions may enlarge slowly and can cause localized retinal atrophy, occasionally leading to visual field defects.
The most critical complication is not ocular but systemic--risk of colorectal carcinoma in patients with FAP. Rarely, malignant transformation of CHRPE itself has been reported, but this is exceedingly uncommon.
Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE) consists of benign melanocytic lesions of the retinal pigment epithelium (RPE). These lesions may be solitary, grouped, or multiple, and their clinical significance ranges from harmless incidental findings to markers of systemic disease.
CHRPE lesions are typically flat, well-demarcated, and darkly pigmented, appearing gray-brown to jet black. Many lesions show characteristic depigmented lacunae (pale areas) or a surrounding halo. They are most commonly located in the superotemporal fundus and usually measure about 1–2 disc diameters, though larger lesions can occur.
Three main patterns are recognized:
1. Solitary CHRPE
These are single, flat lesions with smooth or scalloped borders. They may slowly enlarge over time and can develop increasing depigmentation. They are generally benign and not associated with systemic disease.
2. Grouped CHRPE (“bear tracks”)
These consist of multiple small, round pigmented spots arranged in clusters. They are often unilateral and confined to one retinal quadrant. Despite their striking appearance, they have no systemic associations and are considered benign variants.
3. Multiple bilateral CHRPE associated with Familial adenomatous polyposis
This pattern is clinically important. Lesions are typically:
• Multiple (>4 per eye)
• Bilateral
• Oval with irregular borders
• Often show “fishtail” depigmentation at the edges
These findings may indicate an underlying mutation in the APC gene, a tumor suppressor gene responsible for familial adenomatous polyposis (FAP).
Epidemiologically, CHRPE is found in approximately 1.2% of the population, while FAP occurs in about 1 in 13,000–18,000 individuals. Notably, 70–80% of patients with FAP have CHRPE-like lesions, making this an important ocular marker.
Pathophysiologically, CHRPE arises from hypertrophy and hyperplasia of RPE cells, which contain abundant melanin. Solitary and grouped lesions are typically composed of a single layer of enlarged pigmented cells, while FAP-associated lesions may show multilayering and retinal involvement.
History is crucial, especially in patients with multiple lesions. Clinicians should ask about:
• Family history of colon cancer or polyps
• Gastrointestinal symptoms (e.g., rectal bleeding, abdominal pain)
• Associated tumors or syndromes
On examination, dilated funduscopy reveals the characteristic pigmented lesions. The presence of bilateral, multiple, widely spaced lesions should raise suspicion for FAP and prompt systemic evaluation.
Diagnostic tools include:
• Fundus photography for documentation and monitoring
• Autofluorescence imaging (lesions appear hypoautofluorescent)
• Fluorescein angiography (may show capillary changes)
• Visual field testing (for large lesions causing scotomas)
If FAP is suspected, referral for genetic testing (APC gene) and gastrointestinal evaluation is essential. Screening with colonoscopy or sigmoidoscopy typically begins in childhood (around age 10).
Management depends on the type:
• Solitary and grouped CHRPE: No treatment required; routine observation
• FAP-associated CHRPE: Requires systemic surveillance and management, including possible colectomy depending on polyp burden
Follow-up includes periodic ophthalmic examination with photographic documentation to monitor for growth or changes.
Prognosis for isolated CHRPE is excellent. Lesions may enlarge slowly and can cause localized retinal atrophy, occasionally leading to visual field defects.
The most critical complication is not ocular but systemic--risk of colorectal carcinoma in patients with FAP. Rarely, malignant transformation of CHRPE itself has been reported, but this is exceedingly uncommon.
